Pharmaceutical industry news
Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.
48,396 stories, page 37 of 807
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry
NCT07513376: A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
Study type: INTERVENTIONAL. Phase: PHASE3.
ClinicalTrials.govOriginal source






